220 related articles for article (PubMed ID: 15450343)
21. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
Gladman DD; Antoni C; Mease P; Clegg DO; Nash P
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii14-7. PubMed ID: 15708927
[TBL] [Abstract][Full Text] [Related]
22. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.
Healy PJ; Helliwell PS
Arthritis Rheum; 2008 May; 59(5):686-91. PubMed ID: 18438903
[TBL] [Abstract][Full Text] [Related]
23. Pediatric psoriasis and psoriatic arthritis.
Lewkowicz D; Gottlieb AB
Dermatol Ther; 2004; 17(5):364-75. PubMed ID: 15379771
[TBL] [Abstract][Full Text] [Related]
24. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and differential diagnosis of psoriatic arthritis on basis of follow up of 215 cases].
Seszták M; Koó E; Farkas V; Weisz M
Orv Hetil; 1995 Apr; 136(16):811-6. PubMed ID: 7644186
[TBL] [Abstract][Full Text] [Related]
26. Psoriatic arthritis--what the dermatologist needs to know.
Laws P; Barton A; Warren RB
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1270-7. PubMed ID: 20384693
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices.
Gottlieb AB; Mease PJ; Mark Jackson J; Eisen D; Amy Xia H; Asare C; Stevens SR
J Dermatolog Treat; 2006; 17(5):279-87. PubMed ID: 17092858
[TBL] [Abstract][Full Text] [Related]
28. Biomarker development in psoriatic arthritis.
Ritchlin C
J Rheumatol Suppl; 2012 Jul; 89():57-60. PubMed ID: 22751594
[TBL] [Abstract][Full Text] [Related]
29. Severity levels in psoriasis: a separate 'very severe' category not required.
Kulkarni AS; Horn E; Balkrishnan R; Feldman S
J Dermatolog Treat; 2009; 20(1):48-51. PubMed ID: 18651301
[TBL] [Abstract][Full Text] [Related]
30. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets.
Kerschbaumer A; Fenzl KH; Erlacher L; Aletaha D
Wien Klin Wochenschr; 2016 Nov; 128(21-22):791-795. PubMed ID: 27822746
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
Pomerantz RG; Mody E; Husni ME; Qureshi AA
J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
[TBL] [Abstract][Full Text] [Related]
32. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
Bongartz T; Coras B; Vogt T; Schölmerich J; Müller-Ladner U
Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756
[TBL] [Abstract][Full Text] [Related]
33. Psoriatic arthritis is a joint-damaging disease--a call for action!
Taylor WJ; Helliwell PS
Rheumatology (Oxford); 2007 Dec; 46(12):1747-8. PubMed ID: 18032535
[No Abstract] [Full Text] [Related]
34. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
[No Abstract] [Full Text] [Related]
35. Outcome measures in psoriatic arthritis.
Gladman DD; Mease PJ; Krueger G; van der Heidje DM; Antoni C; Helliwell PS; Kavanaugh AF; Nash P; Ritchlin CT; Strand CV; Taylor W
J Rheumatol; 2005 Nov; 32(11):2262-9. PubMed ID: 16265714
[TBL] [Abstract][Full Text] [Related]
36. Psoriatic arthropathy: where now?
Slobodin G; Rosner I; Rozenbaum M; Boulman N; Kessel A; Toubi E
Isr Med Assoc J; 2009 Jul; 11(7):430-4. PubMed ID: 19911496
[No Abstract] [Full Text] [Related]
37. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F
Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346
[No Abstract] [Full Text] [Related]
38. Assessment tools in psoriatic arthritis.
Mease PJ
J Rheumatol; 2008 Jul; 35(7):1426-30. PubMed ID: 18609738
[TBL] [Abstract][Full Text] [Related]
39. [Management of severe synovial arthritis with drugs].
Korpela M
Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232
[No Abstract] [Full Text] [Related]
40. Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods.
Taylor WJ
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii110-2. PubMed ID: 15708923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
